Modern Diagnostic & Research Centre Limited provides diagnostic and related healthcare tests services to individual patients, corporates, hospitals and other healthcare providers in India. It offers diagnostic tests, such as complete blood counts, liver and kidney function tests, lipid profiles, hormone analysis, autoimmune disease markers, cancer screening, and infectious disease testing; and radiology services magnetic resonance imaging, computerized tomography scan (CT) scans, PET-CT, ultrasound, color Doppler studies, digital X-rays, mammography, and interventional radiology, as well as heart lab, neuro lab and laboratory, electrocardiogram, cone beam CT, orthopantomogram, pulmonary function tests, etc. The company also provides pathology services, such as haematology, biochemistry, clinical pathology, serology, immunology, histopathology, cytopathology, microbiology, molecular diagnostics, and genetic testing. In addition, it offers value-added services, including home collection
| Current Price | ₹52.00 |
|---|---|
| Market Cap | ₹79 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Health Care; Health Care Equipment and Services; Health Care Providers and Services; Health Care Services; Medical Laboratory Services; Blood and Chemistry Analysis Laboratory Services; Diagnostic Imaging Centers; X-ray Laboratory Services |
| P/E Ratio | 6.4 |
| Beta (1Y) | 1.2 |
1. Radiology-24.8% 2. Pathology-75.2%
Modern Diagnostic & Research C is trading at ₹52.00, with a market capitalisation of ₹79 Cr.
Modern Diagnostic & Research C operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Health Care; Health Care Equipment and Services; Health Care Providers and Services; Health Care Services; Medical Laboratory Services; Blood and Chemistry Analysis Laboratory Services; Diagnostic Imaging Centers; X-ray Laboratory Services).
Modern Diagnostic & Research C has a P/E of 6.4.